TipRanks
Advertisement
Advertisement

ACAD Stock Latest News

Acadia Pharmaceuticals Reaches Preliminary Derivative Lawsuit Settlement
Company AnnouncementsAcadia Pharmaceuticals Reaches Preliminary Derivative Lawsuit Settlement
9d ago
8K
ACAD
Acadia Pharmaceuticals price target raised to $38 from $37 at Deutsche Bank
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $38 from $37 at Deutsche Bank
27d ago
ACAD
ACADIA: EU Orphan Drug Launch Underscores Pricing Strength; Buy Rating and $37 Price Target Reaffirmed
PremiumRatings
ACADIA: EU Orphan Drug Launch Underscores Pricing Strength; Buy Rating and $37 Price Target Reaffirmed
27d ago
ACAD
ACADIA: Buy Rating Reiterated as Daybue Momentum Builds and Key Pipeline Catalyst Nears; Price Target Maintained at $36
PremiumRatings
ACADIA: Buy Rating Reiterated as Daybue Momentum Builds and Key Pipeline Catalyst Nears; Price Target Maintained at $36
27d ago
ACAD
Acadia Pharmaceuticals price target raised to $28 from $27 at Morgan Stanley
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $28 from $27 at Morgan Stanley
27d ago
ACAD
Analyst Lifts ACADIA Price Target to $40 on Favorable Risk‑Reward and RADIANT Alzheimer’s Psychosis Upside
PremiumRatingsAnalyst Lifts ACADIA Price Target to $40 on Favorable Risk‑Reward and RADIANT Alzheimer’s Psychosis Upside
27d ago
ACAD
Acadia Pharmaceuticals price target raised to $40 from $39 at Citi
Premium
The Fly
Acadia Pharmaceuticals price target raised to $40 from $39 at Citi
27d ago
ACAD
Acadia Pharmaceuticals announces EC marketing authorization for Daybu
Premium
The Fly
Acadia Pharmaceuticals announces EC marketing authorization for Daybu
28d ago
ACAD
Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.
PremiumMarket News
Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.
1M ago
JNJ
MRK
Acadia Pharmaceuticals price target raised to $49 from $45 at UBS
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $49 from $45 at UBS
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $41 from $38 at Needham
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $41 from $38 at Needham
1M ago
ACAD
ACADIA Pharmaceuticals: Buy Rating Reiterated on Undervalued Growth Story; $36 Price Target Unchanged
PremiumRatings
ACADIA Pharmaceuticals: Buy Rating Reiterated on Undervalued Growth Story; $36 Price Target Unchanged
1M ago
ACAD
ACADIA Pharmaceuticals Earnings Call Signals Growth Momentum
PremiumCompany AnnouncementsACADIA Pharmaceuticals Earnings Call Signals Growth Momentum
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $27 from $26 at Morgan Stanley
Premium
The Fly
Acadia Pharmaceuticals price target raised to $27 from $26 at Morgan Stanley
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $39 from $35 at Citi
Premium
The Fly
Acadia Pharmaceuticals price target raised to $39 from $35 at Citi
1M ago
ACAD
ACADIA: Buy Rating Reiterated as Analyst Sees Favorable Risk-Reward Ahead of RADIANT Readout; $37 Price Target Unchanged
PremiumRatings
ACADIA: Buy Rating Reiterated as Analyst Sees Favorable Risk-Reward Ahead of RADIANT Readout; $37 Price Target Unchanged
2M ago
ACAD
Acadia Pharmaceuticals: Buy Rating Reiterated as Growth Drivers Strengthen; Price Target Maintained at $36
PremiumRatings
Acadia Pharmaceuticals: Buy Rating Reiterated as Growth Drivers Strengthen; Price Target Maintained at $36
2M ago
ACAD
Acadia Pharmaceuticals price target raised to $31 from $30 at BofA
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $31 from $30 at BofA
2M ago
ACAD
ACADIA: Hold Rating Reaffirmed as Strong Daybue Sales Drive FY26 Guidance Raise; $26 Price Target Maintained
PremiumRatings
ACADIA: Hold Rating Reaffirmed as Strong Daybue Sales Drive FY26 Guidance Raise; $26 Price Target Maintained
2M ago
ACAD
Acadia Pharmaceuticals price target raised to $25 from $23 at Oppenheimer
PremiumThe FlyAcadia Pharmaceuticals price target raised to $25 from $23 at Oppenheimer
2M ago
ACAD
Acadia Pharmaceuticals price target raised to $37 from $36 at RBC Capital
Premium
The Fly
Acadia Pharmaceuticals price target raised to $37 from $36 at RBC Capital
2M ago
ACAD
Acadia Pharmaceuticals price target raised to $36 from $35 at Mizuho
Premium
The Fly
Acadia Pharmaceuticals price target raised to $36 from $35 at Mizuho
2M ago
ACAD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >